[ad_1]
This image is provided by AcelRx Pharmaceuticals shows the dispenser and a tablet for the company Dsuvia. On Friday, Nov. 2. 2018, U.S. regulators announced the approval of the fast-acting, super-potent opioid tablet as an alternative to IV painkillers used in hospitals. (Craig Sherod Photography / AcelRx Pharmaceuticals via AP)
TRAVERSE CITY, Mich. (WPBN / WGTU) – A new opioid was approved by the FDA last week, while it was not meant to get into the hands of anyone outside a medical facility, it's still causing concern.
Dsuvia is an opioid that is meant to be a powerful, non-injectable bread reliever only, but since it's 10 times more potent than Fentanyl many are questioning why we need it.
"What's their thinking?" It's obviously not thinking about what's best for the American people, "said Kathy Dugan.
Even in the wake of the opioid epidemic, the FDA approved a new drug, Dsuvia, which is about 10 times more potent than Fentanyl.
Families Against Narcotics VP and pharmacist Kathy Dugan says because of its strength, she's concerned about accidental overdoses.
"The reason they gave us is that they would like to have a pain that was not injectable, that it would work quickly, so you could get it under your tongue and it's a pretty powerful opioid," said Dugan.
And even though it will only be allowed to medical facilities with strict regulations, that does not ease everyone's concerns.
"My daughter Dana lost her battle to opioids in an overdose," said Nancy Dow. "Her addiction began in a medical facility."
Dow says for that reason, she thinks that this drug is more likely to become addicted to opioids, when we are doing so much to fight the epidemic.
"This particular drug will not make it out of the medical office, which I have concerns about," said Dow. "Even if it is not there, there are other opioids out there that these people will be able to get to."
While Dugan does not necessarily think it will make its way to the street, it says it never did, it will be deadly.
"So, I do not like it being an issue," said Dugan. "It's just more, 'why do we need another one."
"When we introduce a new drug like this I feel like we've gone backwards," said Dow.
Dugan also says she will not think this drug will make her way to local hospitals anytime soon.
Since it's just approved, it's very much needed.
Hospitals can just use the bread relievers they already have.
Source link
